Table 1: a) Concentration of each PAHs in the mixtures employed for calibration and validation.
Calibration | B[a]P (ng mL-1) | B[b]F (ng mL-1) | B[a]A (ng mL-1) | Chry (ng mL-1) |
1 | 0.75 | 40 | 105 | 135 |
2 | 23.75 | 40 | 105 | 135 |
3 | 12.25 | 20 | 105 | 135 |
4 | 12.25 | 40 | 195 | 135 |
5 | 12.25 | 40 | 105 | 25 |
6 | 12.25 | 40 | 105 | 245 |
7 | 6.5 | 30 | 60 | 80 |
8 | 18 | 30 | 60 | 80 |
9 | 6.5 | 50 | 60 | 80 |
10 | 18 | 50 | 60 | 80 |
11 | 18 | 30 | 150 | 80 |
12 | 6.5 | 50 | 150 | 80 |
13 | 18 | 50 | 150 | 80 |
14 | 6.5 | 30 | 60 | 190 |
15 | 18 | 30 | 60 | 190 |
16 | 18 | 50 | 60 | 190 |
17 | 6.5 | 30 | 150 | 190 |
18 | 6.5 | 50 | 150 | 190 |
19 | 18 | 50 | 150 | 190 |
20 | 12.25 | 40 | 105 | 135 |
21 | 12.25 | 40 | 105 | 135 |
b) Concentration of each PAHs in the mixtures employed for calibration and validation (continuation).
Validation | B[a]P (ng mL-1) | B[b]F (ng mL-1) | B[a]A (ng mL-1) | Chry (ng mL-1) |
1 | 12.3 | 60 | 105 | 135 |
2 | 12.3 | 40 | 15 | 135 |
3 | 6.5 | 30 | 150 | 80 |
4 | 6.5 | 30 | 60 | 190 |
5 | 18 | 30 | 150 | 190 |
6 | 12.3 | 40 | 105 | 135 |